Search / Trial NCT06616012

Evaluation of Intravascular Monitoring of Partial PRessure of Oxygen for Neonatal IntensiVE Care Patients -3

Launched by NEOSENSE TECHNOLOGIES · Sep 24, 2024

Trial Information

Current as of October 04, 2024

Enrolling by invitation

Keywords

Neonatal Arterial Oxygen Tension Oxygen Therapy

Description

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Sick newborn infants where the clinical routine indicates use of an umbilical catheter. At least one of the criteria below should be fulfilled:
  • * The infant needs invasive measurement of blood pressure.
  • * The infant needs repetitive sampling of blood.
  • * The infant needs prolonged infusion(s) \> 2 days.
  • * The infant needs infusion of vessel irritating and potentially vessel harming solutions.
  • * The infant is born extremely preterm (before 28+0 weeks gestational age).
  • * A newborn infant with severe respiratory disorder, requiring oxygen treatment (more than 40% Fraction of inspired oxygen (FiO2)).
  • * The infant is undergoing therapeutic hypothermia following asphyxia \"oxygen deficiency at birth\").
  • * The infant has a severe infection/sepsis.
  • Also:
  • • Signed informed consent form by both parents (or guardians), (if the infant has only one parent (or guardian) one informed consent is required).
  • Exclusion Criteria:
  • * Gastroschisis
  • * Omphalocele
  • * Peritonitis
  • * Necrotizing enterocolitis
  • * Omphalitis
  • * The infant has a severe infection/sepsis
  • * Expected MRI investigation within the 7 first days after birth
  • * The infants birth weight is below 750 g
  • * The infant is born before week 25+0
  • * Local vascular compromise in lower limbs or buttocks area, or portal venous hypertension

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Stockholm, , Sweden

Stockholm, , Sweden

Gothenburg, Halland, Sweden

Lund/Malmö, Skåne, Sweden

Uppsala, Uppland, Sweden

Västerås, Västmanland, Sweden

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0